Life Sciences Presentation: A Call to Arms - Data Standards in Collaborative Research
Dr. Martin Leach, Executive Director, Basic Research and Biomarker IT, Merck Research Laboratories.
Arguing that the rate of development and adoption of research data standards has been unsatisfactory, Martin challenges the life sciences community in general - and the biopharma community in particular - to leverage lessons learnt in the clinical realm. He aims to extend recent successes in the adoption of data standards in areas like gene expression analysis into other critical areas, such as pharmacology and translational medicine.
Joined by colleagues from several leading life sciences organizations, Martin's address will be followed immediately by a panel discussion probing what can and is being done toward the development and adoption of research data standards and asking 'if not, why not.'
Life Sciences Panel: Data Standards in Collaborative Research - If Not, Why Not?
- Chris Bouton, CEO, Entagen and Adjunct Assistant Prof., Boston University
- Jens Hoefkens, Managing Director, GeneData USA
- Michelle Pontinen, R&D Practice Leader, Capgemini US, LLC
- And Others...
Moderated by Joseph Cerro, President, The Schooner Group, LLC
This is a featured event in the MassTLC LIFE SCIENCES CLUSTER LECTURE SERIES on "TECHNOLOGY and LIFE SCIENCES COLLABORATION"
About the series: More R&D dollars are invested in collaborative research across organizations than ever. A collaboration's outcome can make or break an emerging biotechnology company. Most major Biopharma firms now list greater success in collaborative research as a top priority for 2009. In this series, the Life Sciences Cluster asks how the IT function - a potentially crucial enabler - helps or hinders collaborative research, while spotlighting effective collaboration strategies.